tailieunhanh - Simultaneous determination of newly developed antiviral agents in pharmaceutical formulations by HPLC‑DAD

Ombitasvir/paritaprevir/ritonavir/dasabuvir (Viekira Pak®) are the newest medicines approved for use in the treatment of hepatitis C virus (HCV) and are available in tablet form as an oral combination. Specifically, these agents are indicated in the treatment of HCV in patients with genotype 1 infection. | Simultaneous determination of newly developed antiviral agents in pharmaceutical formulations by HPLC DAD

TỪ KHÓA LIÊN QUAN